Efficacy versus effectiveness: The HORIZON Pivotal Fracture Trial and its emulation in Claims Data.
Elvira D'AndreaSebastian SchneeweissJessica M FranklinSeoyoung C KimRobert J GlynnSu Been LeeShirley V WangPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
Real-world emulation of the HORIZON-PFT found that zoledronic acid reduced hip fractures risk over an 18-month follow-up period. Limited adherence in clinical practice diminished the magnitude of its preventive effect and precluded long-term estimation of effectiveness in this setting.